Swedbank AB Purchases 200,000 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Swedbank AB raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 14.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,629,602 shares of the medical device company's stock after purchasing an additional 200,000 shares during the quarter. Swedbank AB owned 0.82% of Cooper Companies worth $149,809,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in the stock. Ashton Thomas Securities LLC bought a new stake in Cooper Companies in the third quarter valued at about $25,000. Covestor Ltd grew its stake in shares of Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company's stock valued at $37,000 after purchasing an additional 200 shares during the period. Brown Brothers Harriman & Co. raised its holdings in shares of Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock worth $46,000 after buying an additional 275 shares in the last quarter. Friedenthal Financial bought a new position in shares of Cooper Companies during the 3rd quarter worth approximately $50,000. Finally, Cromwell Holdings LLC bought a new position in shares of Cooper Companies during the 3rd quarter worth approximately $52,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on COO. StockNews.com lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Citigroup reduced their price objective on Cooper Companies from $116.00 to $115.00 and set a "buy" rating on the stock in a research note on Friday, December 6th. Morgan Stanley lowered their target price on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research note on Friday, December 6th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Wells Fargo & Company raised their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $117.00.

Cooper Companies Trading Up 0.1 %

Shares of COO stock traded up $0.10 during trading hours on Thursday, reaching $98.10. The company had a trading volume of 951,374 shares, compared to its average volume of 1,420,120. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The company has a 50 day moving average of $95.91 and a 200 day moving average of $99.54. The firm has a market cap of $19.58 billion, a price-to-earnings ratio of 50.31, a P/E/G ratio of 2.41 and a beta of 0.99.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts' consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $1.03 billion. During the same period in the prior year, the business posted $0.87 EPS. Cooper Companies's revenue was up 9.8% on a year-over-year basis. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.